# Drug development in Alzheimer’s disease: the path to 2025

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/drug-development-in-alzheimer-s-disease-the-path-to-2025/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jeffrey L. Cummings,Paul Aisen,Bruno Dubois,Lutz Frölich,Clifford R. Jack,Roy Jones,John C. Morris,Joel Raskin,Sherie A. Dowsett,Philip Scheltens |
| Citations | 458 |
| DOI | 10.1186/s13195-016-0207-9 |
| Fields | Computer Science,Economics, Econometrics and Finance |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1186/s13195-016-0207-9 |
| OpenAlex ID | https://openalex.org/W2520082135 |
| PMID | 27646601 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Roy Jones](https://scholariq.org/researchers/roy-jones/)

## Paper primary topic

- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)

## Paper topics

- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.